Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 52Insulin Resistance 12Metabolic Syndrome 4Hyperandrogenism 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Obesity 3Breast Neoplasms 3Weight Loss 2Rare Diseases 2Infertility, Female 2Hyperinsulinism 2Endocrine System Diseases 2Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostatic Neoplasms 1Premature Birth 1Obesity, Morbid 1Metformin 1Menstruation Disturbances 1Inflammation 1Infertility 1Hyperglycemia 1Head and Neck Neoplasms 1Glucose Intolerance 1Endometrial Neoplasms 1Diabetes Mellitus 1Depression 1

Interventions

Caloric Restriction 2Yoga 1Robotic Surgical Procedures 1Population Groups 1Metformin 1Hysterectomy 1Folic Acid 1Diet 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Menstruation Disturbances × Metformin × Clear all
NCT02198417 2018-08-16

Metformin Treatment in Polycystic Ovary Syndrome (PCOS)

Massachusetts General Hospital

Phase NA Unknown
20 enrolled

Acne Vulgaris, Infertility, Menstruation Disturbances, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡